From: A multi-center study of fidaxomicin use for Clostridium difficile infection
n | Early episodes | Later episodes | Overall (n = 102) n (%) | |
---|---|---|---|---|
Episode 1 (n = 37) | Episode 2 (n = 32) | Episode ≥ 3 (n = 33) | ||
Clinical cure | 25 | 25 | 29 | 79 (77 %) |
Recurrent CDI | 6 | 7 | 8 | 21 (21 %) |
Re-hospitalizationa | 9 | 13 | 10 | 32 (31 %) |
Mortality | 4 | 4 | 0 | 8 (8 %) |